HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Monday, 23 April 2012

Recent CUAs

Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers.  35 papers were listed this time. Here's a couple in our areas of research interest:

The Diabetes Prevention Program Research Group. The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention: An intent-to-treat analysis of the DPP/DPPOS. Diabetes Care. 2012 Apr;35(4):723-730. PubMed PMID: 22442395.

Zhuo X, Zhang P, Selvin E, et al. Alternative HbA1c Cutoffs to Identify High-Risk Adults for Diabetes Prevention: A Cost-Effectiveness Perspective. Am J Prev Med. 2012 Apr;42(4):374-81. PubMed PMID: 22424250.

Rutten-van Mölken MP, Goossens LM. Cost effectiveness of pharmacological maintenance treatment for chronic obstructive pulmonary disease: a review of the  evidence and methodological issues. Pharmacoeconomics. 2012 Apr 1;30(4):271-302. PubMed PMID: 22409290.

Schwenkglenks M, Toward TJ, Plent S, Szucs TD, Blackman DJ, Baumbach A. Cost-effectiveness of bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitor in the treatment of acute ST-segment elevation myocardial infarction. Heart. 2012 Apr;98(7):544-51. Epub 2012 Feb 7. PubMed PMID: 22313548.